Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Ablation soon after first implantable cardioverter defibrillator shock for ventricular tachycardia ...

Please provide your email address to receive an email when new articles are posted on . A single burst of antitachycardia pacing (ATP) reduced risk for shocks in patients with an implantable ...

WASHINGTON -- Researchers made a strong case that earlier was better when it comes to catheter ablation of ventricular tachycardias (VTs) in people with implantable cardiac defibrillators (ICDs).

December 20, 2006 (Atlanta, GA) - The emotional well-being of ICD recipients makes it imperative that clinicians take steps to reduce the occurrence of both appropriate and inappropriate ICD shocks, a ...

(HealthDay News) — For patients with cardiomyopathy, use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is associated with significantly lower incidence of ...

Combined data from five implantable cardioverter-defibrillator (ICD) trials suggest that it is the underlying arrhythmic disorder, rather than the ICD therapy itself, that affects mortality in these ...

BOSTON -- An oversensing filter for Emblem subcutaneous implantable cardioverter-defibrillators (S-ICDs) halved the risk of inappropriate shocks in real-world practice, a European study found. The ...

The first randomized trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients at high risk of ventricular ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...